We report here, for the first time, the expression in BPDCN cases of cholinergic-related genes and neural-related genes (EDN3, NLGN4X, DCX and UCHL-1) that warrant further investigation. The gene discussed is NLGN4X; the disease is CD4+/CD56+ hematodermic neoplasm.